Press Releases

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

Proscia to Expand Pathology AI Capabilities with Virtual Staining

Delivering a menu of H&E, IHC, and special stains on the Concentriq platform

Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners

Arkivum announces new partnership with unified trial management platform provider PHARMASEAL

Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

Baylor Genetics’ Chief Medical Officer Dr. Christine Eng Named Woman Scientist of the Year in 2025 Stevie® Awards for Women in Business

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced that Chief Medical Officer and Chief Quality Officer Dr. Christine Eng has been named Woman Scientist of the Year in the 22nd annual Stevie Awards for Women in Business.

electronRx to Launch pDx App for Remote Chronic Respiratory Disease Management

● Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patients ● electronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas)

Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration

AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform

DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.

Abselion Launches AAVX and AAV9 Total Capsid Quantification Kits

• Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes • Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistency

Precision BioLogic Leads the Way in Hemophilia Testing: Proven CRYOcheck™ Chromogenic Factor VIII assay now offers expanded utility in anticipation of emerging treatments

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII assay in anticipation of emerging hemophilia treatments such as Mim8, a next generation bispecific antibody for the treatment of hemophilia A. The updated assay will ensure labs are ready and able to deliver accurate results when new treatments become available.

UMass Signed a Non-Exclusive License Agreement with Hongene

UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.

Logical Biological and Bcell Design Announce Strategic Partnership for Engineered Disease State Materials

Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.

Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients

For participating academic medical centers, healthcare systems, and reference laboratories, Proscia Aperture elevates pathology from a diagnostic function to a strategic revenue driver.

Gifthealth + Occam Health: Transforming Patient Access at Scale

Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.

One2Treat raises capital to further accelerate software platform development and relocates offices to support rapid growth

One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.

EpiCypher Launches Fiber-seq, a Breakthrough Multiomic Single-Molecule Genomics Assay

Onvida Health and Ambience Healthcare Launch Frontier Ambient AI Capabilities Inside Epic

Aptamer Group Introduces Novel Biomarker Discovery Service

DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx

Baylor Genetics to Showcase RNA Sequencing Breakthroughs for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its participation in the 2025 Advances in Genome Biology and Technology (AGBT) Precision Health Conference, taking place September 8–10, 2025, in San Diego, CA. The company will present important data underscoring the clinical utility of RNA sequencing in the diagnosis of rare and previously undiagnosed diseases.